Inst Biochimique Drug Patent Portfolio
Inst Biochimique owns 1 orange book drug protected by 1 US patent Given below is the list of Inst Biochimique's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7723390 | Pharmaceutical formulations for thyroid hormones | 14 Mar, 2024 | Expired |
Latest Legal Activities on Inst Biochimique's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Inst Biochimique.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 21 Oct, 2021 | US7723390 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 23 Sep, 2021 | US7691411 |
| Mail Certificate of Correction Memo | 23 Feb, 2021 | US7723390 |
| Certificate of Correction Memo | 18 Feb, 2021 | US7723390 |
| Post Issue Communication - Certificate of Correction | 18 Feb, 2021 | US7723390 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 20 Oct, 2017 | US7723390 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 25 Sep, 2017 | US7691411 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 25 May, 2010 | US7723390 |
|
Recordation of Patent Grant Mailed
Critical
| 25 May, 2010 | US7723390 |
|
Issue Notification Mailed
Critical
| 05 May, 2010 | US7723390 |
| Dispatch to FDC | 21 Apr, 2010 | US7723390 |
|
Application Is Considered Ready for Issue
Critical
| 20 Apr, 2010 | US7723390 |
|
Issue Fee Payment Received
Critical
| 09 Apr, 2010 | US7723390 |
| Entity Status Set To Undiscounted (Initial Default Setting or Status Change) | 09 Apr, 2010 | US7723390 |
|
Issue Fee Payment Verified
Critical
| 09 Apr, 2010 | US7723390 |
Inst Biochimique's Family Patents
Inst Biochimique drugs have patent protection in a total of 9 countries. It's US patent count contributes only to 11.1% of its total global patent coverage. 8 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click
below to unlock the full patent family tree.
Inst Biochimique Drug List
Given below is the complete list of Inst Biochimique's drugs and the patents protecting them.
1. Tirosint
Tirosint is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7723390 | Pharmaceutical formulations for thyroid hormones |
14 Mar, 2024
(6 months ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Tirosint's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List